Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PTACH (Cpd 51) (NCH-51) is a SAHA-based inhibitor of human HDAC. It can potently inhibit the growth of various human Y cells (EC50: 1 to 10 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 72.00 | |
2 mg | In stock | $ 113.00 | |
5 mg | In stock | $ 239.00 | |
10 mg | In stock | $ 348.00 | |
25 mg | In stock | $ 557.00 | |
50 mg | In stock | $ 783.00 | |
100 mg | In stock | $ 1,090.00 | |
500 mg | In stock | $ 2,230.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 227.00 |
Description | PTACH (Cpd 51) (NCH-51) is a SAHA-based inhibitor of human HDAC. It can potently inhibit the growth of various human Y cells (EC50: 1 to 10 μM). |
Targets&IC50 | HDAC:1-10 μM (EC50) |
Kinase Assay | mTOR and PI3K Cellular Assays: Cellular IC50 values for mTOR are determined using p53?/? MEFs. Cells are treated with vehicle or increasing concentrations of Torin 2 for 1 h and then lyse. Phosphorylation of S6K1 Thr-389 is monitored by immunoblotting using a phospho-specific antibody. Meanwhile, cellular IC50 values for PI3Ka are determined based on phosphorylation of Akt Thr-308 in p53?/?/mLST8?/? MEFs or human PC3 cells expressing the S473D mutant of Akt1. |
Synonyms | NCH-51, Cpd 51 |
Molecular Weight | 390.56 |
Formula | C20H26N2O2S2 |
CAS No. | 848354-66-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (140.82 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PTACH 848354-66-5 Chromatin/Epigenetic DNA Damage/DNA Repair Microbiology/Virology Proteases/Proteasome HIV Protease HDAC HIV-1 inhibit NCH-51 Cpd 51 HIV Inhibitor Histone deacetylases hyperacetylation NCH51 Anti-cancer p21WAF1/CIP1 Human immunodeficiency virus SAHA NCH 51 inhibitor